Gene · 2000
NIH grants1,476
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,476
Download this page as JSON| Grant | Title | ELF4 papers | Newest fiscal year |
|---|---|---|---|
| R01CA229164 | Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs) | 1 | 2023 |
| R01CA230631 | Targeting Metabolic Liabilities of Leukemia-Initiating Cells | 1 | 2023 |
| R01CA232256 | An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin | 1 | 2023 |
| R01CA233490 | Genetic and Epigenetic Biomarkers for B-cell Lymphoma | 1 | 2023 |
| R01CA237027 | Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC | 1 | 2023 |
| R01CA241661 | Modular approach for the delivery of antibodies into the cytoplasm of cells | 1 | 2023 |
| R01CA243793 | RPMS1 circular RNAs in EBV malignancies | 1 | 2023 |
| R01DK044234 | Autophagy modulates liver injury and inflammation through cell signaling effects | 1 | 2023 |
| R01GM060980 | Regulation and Function of SUMO Protein Modification | 1 | 2023 |
| R01GM089778 | Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5 | 1 | 2023 |
| R01GM113033 | Collaboration of chromatin remodeling and signaling pathways in pluripotency | 1 | 2023 |
| R01GM136737 | Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog | 1 | 2023 |
| R01GM137425 | Decoding the bridges and barriers to cellular reprogramming and lineage identity | 1 | 2023 |
| R01GM137605 | Nuclear mechanobiology in confined migration | 1 | 2023 |
| R01GM140635 | Systematic Discovery of Bioactivation-Associated Structural Alerts | 1 | 2023 |
| R01HD068901 | Transcriptional networks coordinating luminal environment in the human epididymis: the role of the androgen receptor. | 1 | 2023 |
| R01HL060917 | Nitric Oxide in Pulmonary Hypertension | 1 | 2023 |
| R01HL109942 | Genetic Predisposition To Thoracic Aortic Aneurysms/Dissections | 1 | 2023 |
| R01HL118183 | Myeloid cells are critical in inflammatory heart disease | 1 | 2023 |
| R01HL149746 | Potassium channels, membrane potential, and CHD | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2000/grants?page=18